GlassScriptPhysician profile
Cheyenne Tobler
NPI 1164092599
$962.16
in general payments reported to CMS, 2019-2025
10 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.65 · 2022: $39.24 · 2023: $147 · 2024: $456 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $392.18 | 2021-2025 | Triathlon, Mako, Salvation |
| Depuy Synthes Sales INC. | $199.98 | 2022-2024 | Orthovisc, Monovisc |
| Bioventus LLC | $107.65 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Smith+Nephew, INC. | $68.76 | 2023-2024 | Pico 7, Evos, Trigen Intertan |
| Avanos Medical | $63.45 | 2023-2024 | Trivisc Sodium Hyaluronate, On-Q* Pump and Accessories |
| Fidia Pharma USA INC. | $32.24 | 2025 | Hymovis |
| Kci USA, INC. | $31.22 | 2023 | Prevena |
| Molnlycke Health Care US, LLC | $28.49 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Nalu Medical, INC. | $22.14 | 2024 | Nalu Neurostimulation System |
| Ferring Pharmaceuticals INC. | $16.05 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheyenne Tobler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.